基于SWOT分析法的药品带量采购政策研究

Studying on The Drug Quantity Purchasing Policy Based on SWOT Analysis

药品带量采购政策的试点在全国范围内引起了医疗卫生领域的高度重视及关注,政策旨在进一步解决群众“看病难,看病贵”的问题。文章以SWOT分析法对带量采购政策进行了分析,分别从带量采购政策内部的优势和劣势以及来自外部环境的机会和威胁等不同维度进行了横向研究,再从四个组合策略对政策进行了纵向的建议设想。研究认为,带量采购政策是我国医疗体制改革道路上的重要成果,是消除医疗市场灰色地带,摒弃以药养医,探索医药分家的有效手段。最后,对进一步推动带量采购提出了针对性对策和建议。

The pilot of Drug Quantity Purchasing Policy has attracted great attention to medical and health field throughout China which aims to further solve the problem of"difficult and expensive to receive medical treatment". The policy was studied with SWOT analysis method from the aspeets of internal advantages and weaknesses, opportunities and threats from external environment. And suggestions and assumptions were carried out from four combination strategies. The procurement policy is an important achievement of medical system reform in China, and a effective way to eliminate the grey area of medical market, discard drug ablolishing policy, and explore the separation of clinic from pharmacy. Based on which, countermeasures and suggestions to promote the policy are put forward.